Why Can’t Nerve Cells Regenerate After an Injury?

Nerve cells in the brain and spinal cord are remarkably bad at regrowing after damage, and the reasons turn out to be both external and internal. The adult central nervous system creates a hostile chemical environment around an injury site while the neurons themselves have largely shut down the molecular machinery they once used to extend long fibers during early development. This double failure stands in sharp contrast to nerves outside the brain and spinal cord, which can regenerate over impressive distances. Understanding why the central nervous system stalls has become one of the most active areas in neuroscience, and the picture that has emerged over the past two decades is more layered than most people expect.

Not All Nerve Cells Are Equally Stuck

The first thing to clear up is that the blanket statement “nerve cells can’t regenerate” is only half true. It applies to the central nervous system, meaning the brain and spinal cord. In the peripheral nervous system, which includes the nerves running through your arms, legs, and torso, substantial regrowth and functional recovery can happen in adults after an injury.¹ A severed nerve in your hand, for instance, can slowly reconnect over weeks or months. A severed tract in the spinal cord typically cannot.

One of the biggest differences between these two systems comes down to how the surrounding support cells respond to damage. In the peripheral nervous system, the glial cells actively help. In the central nervous system, the glial cells actively hinder.² Same type of cell, radically different behavior depending on location. That distinction sets the stage for everything else that goes wrong inside the brain and spinal cord after injury.

The Glial Scar and Its Chemical Wall

When a nerve fiber in the central nervous system is damaged, the surrounding support cells called astrocytes respond by forming a dense barrier known as the glial scar. This scar has a useful short-term purpose: it walls off the injury, limits the spread of inflammation, and protects surviving tissue. But it also creates a chemical environment that actively blocks any attempt at regrowth.

The scar tissue produces molecules called chondroitin sulfate proteoglycans, which are especially potent at preventing nerve fibers from pushing through.³ Think of these molecules as a sticky chemical mesh that nerve fibers cannot penetrate. Meanwhile, the damaged myelin, the insulating coating around nerve fibers, releases its own set of inhibitory proteins. Together, these signals from the scar and from damaged myelin present what researchers describe as a major hurdle for any regrowing axon.⁴

Among the myelin-derived inhibitors, three proteins have received the most attention: Nogo, MAG, and OMgp. These molecules work through signaling pathways inside the neuron that cause the growing tip of the nerve fiber to collapse and retract. One of the key internal pathways that carries this stop signal is the RhoA/ROCK pathway. In animal experiments, blocking this pathway can reverse the inhibitory effects and promote some sprouting and functional recovery.⁵ The fact that blocking a single signaling cascade can partially restore growth underscores how actively the central nervous system is suppressing regeneration, rather than simply lacking the capacity for it.

Neurons Lose Their Growth Program as They Mature

Even if you could strip away every inhibitory molecule from the injury site, mature central nervous system neurons still struggle to regrow. The problem is not only the environment; it is the neurons themselves. During embryonic development, neurons extend axons over long distances with ease, guided by internal growth programs that are humming along at full power. After the nervous system finishes wiring itself, those programs get dialed way down.

A family of gene regulators called KLF transcription factors illustrates this clearly. Some members of this family promote axon growth, while others suppress it. As the brain matures, the growth-promoting KLFs are gradually turned off and the growth-suppressing ones are turned on.⁶ When researchers knocked out one of the suppressive members, KLF4, in retinal neurons, those neurons showed increased axon growth both in a dish and after optic nerve injury in living animals. Conversely, artificially activating a growth-promoting member, KLF7, in the corticospinal tract (the main pathway for voluntary movement) promoted axon regrowth in adult mice.⁷

Another key internal brake involves a signaling hub called the mTOR pathway, which governs how aggressively cells build new proteins and grow. In adult central nervous system neurons, a protein called PTEN keeps this pathway suppressed. When researchers deleted PTEN in adult retinal ganglion cells in mice, they saw robust axon regeneration after optic nerve injury.⁸ This was a landmark finding because it showed that the neuron’s internal growth machinery has not been dismantled; it has been switched off. The wiring diagram for regeneration still exists inside the cell. The cell just is not reading it.

An Epigenetic Lock on the Growth Genes

The shutdown of growth programs goes deeper than individual signaling pathways. It extends to how the DNA itself is packaged. In mature neurons, the genes needed for axon growth become physically less accessible because of chemical modifications to the DNA and the proteins that wrap it. These modifications, part of the cell’s epigenetic regulation, act like a lock on a filing cabinet: the blueprints are still inside, but the cabinet is sealed shut.

Research has identified changes in DNA methylation, histone acetylation, and overall DNA accessibility as key elements in this process.⁹ One study demonstrated that actively removing certain methyl groups from DNA (a form of DNA demethylation) could lift this barrier and permit axon regeneration in the adult mammalian nervous system.¹⁰ This finding reframed the problem: regeneration is not just about individual molecular switches but about a whole layer of gene regulation that clamps down as the brain matures.

Why Peripheral Nerves Succeed Where the Brain Fails

The peripheral nervous system gets regeneration right through a coordinated effort that the central nervous system simply does not replicate. When a peripheral nerve is cut, the Schwann cells, which are the support cells that insulate peripheral nerve fibers, undergo a dramatic transformation. They reprogram themselves into specialized repair cells that do several things at once: they release growth-promoting signals, they help clear away debris from damaged myelin, they recruit immune cells to assist in the cleanup, and they form physical tracks called bands of Büngner that guide regrowing nerve fibers toward their targets.¹¹ This plasticity, the ability of Schwann cells to completely change their identity after injury, is central to why peripheral nerve repair works as well as it does.¹²

The immune response is another major difference. In the peripheral nervous system, blood-borne immune cells called macrophages rapidly enter the damaged region and clear away myelin debris, which itself contains growth-inhibiting signals. In the central nervous system, this immune response is far weaker. Microglia, the brain’s resident immune cells, are insufficiently activated, and blood-borne macrophages do not significantly enter the degenerating nerve tract. As a result, inhibitory myelin debris persists for a long time in the brain and spinal cord, continuing to block regrowth long after the initial injury.¹³

The blood-brain barrier adds yet another layer of complexity. In the peripheral nervous system, blood vessels are relatively permeable, allowing immune cells and nutrients easy access to an injury site. The brain’s vasculature is far more restrictive. After traumatic brain injury, damage to this barrier can trigger a cascade of secondary problems including swelling, inflammation, and further cell death, compounding the original damage rather than facilitating repair.¹⁴

The Energy Problem

Regrowing a nerve fiber is expensive in cellular energy terms. The growing tip of an axon, called the growth cone, is a dynamic structure that constantly remodels itself as it advances, and that process requires a steady supply of fuel. Mitochondria, the cell’s energy generators, need to physically travel along the axon to the site of injury and concentrate there to power regeneration.

Research has shown that when mitochondrial transport to the injury site is experimentally boosted, regeneration outcomes improve. When it is disrupted, regeneration stalls. Axonal mitochondria are specifically required for growth-cone migration, making energy supply a key bottleneck for injured neurons.¹⁵ This helps explain why long-distance regeneration is so much harder than short-distance sprouting: the farther the growth cone needs to travel, the greater the energy challenge becomes.

Animals That Can Do What Mammals Cannot

The inability to regenerate central nervous system tissue is not a universal law of biology. Salamanders, particularly axolotls, can fully regenerate an injured spinal cord.¹⁶ Zebrafish can do the same, along with regenerating heart tissue and fins. Both species serve as powerful research models precisely because they demonstrate that vertebrate nervous systems are not inherently incapable of repair. Adult mammals have lost something these animals retain.¹⁷

Mammals themselves hint at this lost potential during early life. Neonatal mice can grow axons across a spinal cord injury site in ways that adult mice cannot. Two weeks after a crush injury to the spines of two-day-old mice, nerve fibers from both sensory and motor tracts were visible crossing the injury site. In older animals given the same injury, those fibers were absent.¹⁸ Neonatal spinal cord tissue also has a different extracellular matrix, the structural scaffolding between cells, that appears to play a role in supporting this early regenerative ability.¹⁹ The transition from a permissive neonatal environment to a restrictive adult one is gradual, and pinpointing exactly when and why it happens is an active area of investigation.

How Age Makes Things Worse

Even in the peripheral nervous system, where regeneration does work, it gets less efficient with age. Clinical experience with human patients indicates that nerve repair outcomes decline in later life, and animal experiments generally confirm a measurable drop in regenerative capacity with aging. This decline may be linked to slower transport of materials along the axon. The ability to reinnervate targets and accurately reconnect with former nerve terminals is also impaired in older animals.²⁰ For the central nervous system, where baseline regeneration is already near zero, the additional drag of aging is less studied but presumably compounds every existing barrier.

Therapeutic Strategies Under Investigation

Since regeneration failure has multiple causes, the most promising research strategies tend to attack more than one problem at once. The approaches fall into a few broad categories.

Dismantling the glial scar’s chemical wall has received extensive attention. An enzyme called chondroitinase ABC can break down the inhibitory sugar chains produced by the scar. In animal models of complete spinal cord transection, high-dose treatment with this enzyme reduced scar molecule levels, shrank the lesion area, increased axon regrowth across the injury site, and improved locomotor function compared to untreated animals.²¹ Further work has shown that cleaving those sugar chains triggers additional downstream changes that make the scar environment more permissive for growth.²²

On the intrinsic side, gene therapy is being explored as a way to reactivate the neuron’s silenced growth programs. Viral vectors, particularly adeno-associated viruses, can deliver therapeutic genes to specific populations of neurons. Preclinical work has shown that modulating the PTEN/mTOR pathway and boosting expression of growth-promoting factors through gene delivery can trigger axonal sprouting and synaptic reconnection.²³ A large-scale screen identified roughly 40 genes whose suppression individually promoted retinal ganglion cell axon regeneration after optic nerve crush, suggesting there is no single master switch but rather a web of brakes that can each be released.²³

Bioengineering offers a complementary angle, particularly for peripheral nerve injuries where gaps are too large for natural regrowth. Nerve guide conduits, essentially physical tubes that bridge the gap between severed nerve ends, have been designed with aligned nanofibers that can direct Schwann cells and nerve fibers to grow along their length, promoting longer axon extension than unstructured scaffolds.²⁴ More advanced designs incorporate growth factors, stem cells, and surface patterns that mimic the natural extracellular environment.²⁵

The Reconnection Problem

Getting an axon to regrow is only half the challenge. The regenerated fiber also needs to find the correct target and form functional connections, a process called pathfinding. During embryonic development, a rich set of molecular signposts guides growing axons to their destinations with remarkable precision. In the adult brain, those signposts are different in type, amount, and distribution, making accurate navigation far harder for any axon that does manage to regrow.²⁶

This has been observed directly in experiments where individual cortical neurons were cut and then monitored over months. In every case where regrowth occurred, the regrowing axon followed a different path from the original one, avoiding the lesion site and taking a new trajectory. Some of these regrowing fibers were tracked for up to six months, and they consistently diverged from their former routes.²⁷ This means that even successful regrowth does not simply restore the original circuit. The nervous system may be able to compensate through plasticity, rewiring around the damage, but the rebuilt connection is not a carbon copy of what was lost.

For researchers trying to treat spinal cord injuries or optic nerve damage, pathfinding is a sobering bottleneck. Promoting raw axon growth with gene therapy or scar-digesting enzymes can produce impressive images of fibers crossing an injury site, but whether those fibers reach the right downstream targets and form synapses that restore useful function is a separate and much harder question.

Why the Brain Might Have Evolved This Way

It is worth stepping back and asking why the mammalian brain would evolve such robust anti-regeneration machinery. One prevailing idea is that the scar and the inhibitory environment serve a protective function. The brain is a tightly organized organ where precise wiring matters enormously. Uncontrolled regrowth of nerve fibers after injury could disrupt existing circuits, potentially causing seizures, phantom sensations, or other harmful effects. By sealing off damage and preventing random sprouting, the glial scar may be prioritizing stability of the remaining circuitry over the speculative benefit of regrowth that might go wrong.

Salamanders and zebrafish, by contrast, have smaller and less complex brains with arguably more tolerance for imprecise rewiring. They also have regenerative abilities across many tissue types, not just the nervous system, suggesting their biology never made the same evolutionary trade-off that mammals did. The epigenetic shutdown of growth genes in adult mammalian neurons, as described earlier, may be the molecular signature of that trade-off: a deliberate investment in circuit stability at the cost of repair capacity.

None of this means the trade-off is irreversible. The research discussed above consistently shows that when the right molecular levers are pulled, adult mammalian neurons can be coaxed back into a growth state. The challenge is pulling enough levers at once, overcoming both the hostile environment and the internal shutdown, while still directing the regrowing fibers to useful destinations. Substantial progress has been made in identifying the mechanisms that underlie regenerative failure and in demonstrating that altering those pathways can promote cell survival and axon regeneration.²⁸ Translating those findings from mouse optic nerves and rat spinal cords into therapies for human patients remains the field’s defining challenge, and the gap between a regrowing axon in a lab dish and a person regaining the ability to walk is still enormous.